Descartes' Record Q2 Puts the Organic-Growth Question on the Table

Descartes just reported the best quarter in its history, and its stock is down roughly a third from its high. Read both facts at once and you have the setup.

The logistics-software company said revenues rose 12% year over year to $201.1 million in its fiscal second quarter, with net income up 32% to $50.0 million and an adjusted-EBITDA margin of 47%. Services — the subscription part of the business — were 94% of revenue. Descartes ended July with $401 million in cash, essentially no debt, and it bought back 651,800 of its own shares in the first half of the fiscal year. This is the picture of a compounder that keeps compounding.

And yet the stock sits near $71, down about 18% for the year and roughly 32% below its 52-week high of $105.24. The report didn't cause the decline; it arrived in the middle of one. The reason the market is punishing a company that just did all of this is a single, specific worry, and it is worth separating from the noise.

The economics underneath the worry

First, what Descartes actually is. It runs a software network for the logistics industry — customs and e-commerce compliance, freight visibility, transportation management — that customers pay for on a recurring basis. In the just-reported quarter, services revenue of $188.6 million was up 13% year over year and made up 94% of the top line, an almost purely subscription model. Gross margin was 78%.

That structure produces unusual economics. In the first half of the fiscal year the company generated $156.4 million in operating cash on $394.7 million of revenue, and net income grew 33%. Adoption across this base is what management points to when it wants to reassure investors, and the company has been opening its wallet to buy more of it: it struck two acquisitions in the final two weeks of summer — Transportation Applied Intelligence for freight brokers and Extensiv, a warehouse-management platform bought for roughly $120 million in cash. Both were funded from existing cash rather than new debt, which is the tell that the balance sheet is doing the real financing work.

The organic-growth question the market is pricing

The worry that chased the stock down is that acquisitions are carrying the growth, and that the underlying, organic business has quietly slowed. It is not a baseless fear. On the first-quarter call, management put organic growth in services revenue at just over 9%, and on the same call it estimated its baseline revenue for the quarter — the book before recent acquisitions — at roughly $169 million against the $201.1 million actually reported. Both figures say the same thing: the headline 12% is flattered by deals, and the real, same-store growth is high single digits.

That is the entire debate. It is also why the market has re-priced the stock so hard. Descartes used to carry the kind of multiple reserved for locked-in growth — around 70 times earnings at the start of 2025, by one tally — and that multiple has been cut to roughly half as the organic-growth deceleration became the consensus worry and tariffs and trade-war uncertainty gave it a story. The stock fell even as revenue grew and margins improved, which is the signature of a valuation repricing rather than a broken business.

Put the math next to the fear

Now the honest part, because a fallen stock is not automatically a buy. The bear case is coherent: if organic services growth is stuck at high single digits permanently, and trade volumes fall as protectionism bites, then a software company that grows mostly by buying other companies should not command a premium multiple at all. That version says the de-rating is correct and possibly not finished.

The other reading is that the market has now priced the pessimistic case in. At roughly $71, Descartes trades around 30–35 times trailing earnings and near 18 times trailing EV/EBITDA — call it six times revenue — for a business that still grows revenue at double digits, holds a 47% adjusted-EBITDA margin, converts nearly all of its income to cash, and funds its entire acquisition program from that cash. That is not a cheap stock in absolute terms; it is a high-quality compounder whose premium has been cut roughly in half. The market is no longer paying for organic growth that re-accelerates sharply. It is paying for a machine that keeps grinding out double-digit compounding even if organic growth stays merely decent.

The condition that changes the market's mind is specific and observable: organic services growth re-accelerating, which would prove the slowdown was a trade-war pause rather than a structural ceiling. Until then, the deals keep feeding the top line and the cash keeps funding them, at a multiple that has already conceded the bear case. That is the honest setup — not a screaming bargain, but a defensible one, and certainly not the failure the stock price has been implying.